PURPOSE: This study aims to identify the prevalence and characteristics of long-term adult cancer survivors who use complementary health approaches (CHA). METHODS: Participants completed the Follow-up Care Use Among Survivors (FOCUS) Survey, a cross-sectional investigation of long-term cancer survivors. The use of CHA and reasons for use were assessed. A multivariable logistic regression model was applied to identify if predisposing, enabling, and need characteristics described in the Complementary and Alternative Medicine Healthcare Model were associated with CHA use in the past year. RESULTS: Long-term cancer survivors in the study (N = 1,666) were predominately female (62%) and older (mean age = 69.5), with breast, prostate, colorectal, ovarian, and endometrial cancers. Thirty-three percent of survivors used CHA in the past year. Common reasons for CHA use were to relieve stress (28%), treat or prevent cancer (21%), relieve cancer-related symptoms (18%), and deal with another condition (18%). Predisposing (i.e., higher optimism) and need factors (i.e., experienced cancer-related symptoms, ever had depression/anxiety) were significantly associated with CHA (p-values < .05). Enabling factors (i.e., insurance coverage, financial resources) were not. CONCLUSIONS: Cancer survivors continue to report a high prevalence of recent CHA use more than 5 years after initial diagnosis. Healthcare providers should be aware of increased use of CHA among subgroups of long-term cancer survivors in order to guide safe and optimal use.
PURPOSE: This study aims to identify the prevalence and characteristics of long-term adult cancer survivors who use complementary health approaches (CHA). METHODS:Participants completed the Follow-up Care Use Among Survivors (FOCUS) Survey, a cross-sectional investigation of long-term cancer survivors. The use of CHA and reasons for use were assessed. A multivariable logistic regression model was applied to identify if predisposing, enabling, and need characteristics described in the Complementary and Alternative Medicine Healthcare Model were associated with CHA use in the past year. RESULTS: Long-term cancer survivors in the study (N = 1,666) were predominately female (62%) and older (mean age = 69.5), with breast, prostate, colorectal, ovarian, and endometrial cancers. Thirty-three percent of survivors used CHA in the past year. Common reasons for CHA use were to relieve stress (28%), treat or prevent cancer (21%), relieve cancer-related symptoms (18%), and deal with another condition (18%). Predisposing (i.e., higher optimism) and need factors (i.e., experienced cancer-related symptoms, ever had depression/anxiety) were significantly associated with CHA (p-values < .05). Enabling factors (i.e., insurance coverage, financial resources) were not. CONCLUSIONS:Cancer survivors continue to report a high prevalence of recent CHA use more than 5 years after initial diagnosis. Healthcare providers should be aware of increased use of CHA among subgroups of long-term cancer survivors in order to guide safe and optimal use.
Authors: Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam Journal: J Cancer Surviv Date: 2010-10-06 Impact factor: 4.442
Authors: Erin E Kent; Neeraj K Arora; Julia H Rowland; Keith M Bellizzi; Laura P Forsythe; Ann S Hamilton; Ingrid Oakley-Girvan; Ellen B Beckjord; Noreen M Aziz Journal: Patient Educ Couns Date: 2012-09-28
Authors: Andrea Saini; Alfredo Berruti; Serena Capogna; Manuela Negro; Erica Sguazzotti; Rocco Luigi Picci; Sara Campagna; Vincenzo Dongiovanni; Luigi Dogliotti; Pier Maria Furlan; Luca Ostacoli Journal: Qual Life Res Date: 2010-11-16 Impact factor: 4.147
Authors: Neeraj K Arora; Ann S Hamilton; Arnold L Potosky; Julia H Rowland; Noreen M Aziz; Keith M Bellizzi; Carrie N Klabunde; Wendy McLaughlin; Jennifer Stevens Journal: J Cancer Surviv Date: 2007-03 Impact factor: 4.442
Authors: Keith M Bellizzi; Noreen M Aziz; Julia H Rowland; Kathryn Weaver; Neeraj K Arora; Ann S Hamilton; Ingrid Oakley-Girvan; Gretchen Keel Journal: J Cancer Epidemiol Date: 2012-07-25
Authors: Heather Greenlee; Alfred I Neugut; Laura Falci; Grace Clarke Hillyer; Donna Buono; Jeanne S Mandelblatt; Janise M Roh; Isaac J Ergas; Marilyn L Kwan; Marion Lee; Wei Yann Tsai; Zaixing Shi; Lois Lamerato; Lawrence H Kushi; Dawn L Hershman Journal: JAMA Oncol Date: 2016-09-01 Impact factor: 31.777
Authors: Gabriella M John; Dawn L Hershman; Laura Falci; Zaixing Shi; Wei-Yann Tsai; Heather Greenlee Journal: J Cancer Surviv Date: 2016-02-26 Impact factor: 4.442
Authors: Stephanie J Sohl; Laurel A Borowski; Erin E Kent; Ashley Wilder Smith; Ingrid Oakley-Girvan; Russell L Rothman; Neeraj K Arora Journal: Cancer Date: 2014-11-11 Impact factor: 6.860
Authors: Rebecca A Campo; Karyn L Leniek; Nicole Gaylord-Scott; Keturah R Faurot; Sunyata Smith; Gary Asher; Deborah Porterfield; Susan A Gaylord Journal: Support Care Cancer Date: 2016-04-06 Impact factor: 3.603